Skip to main content
. 2021 Jul 30;13(15):3841. doi: 10.3390/cancers13153841

Figure 3.

Figure 3

HLA-DR level in cytotoxic T cells has prognostic value. Progression-free survival of breast cancer patients divided in HLA-DR high in cytotoxic T cells (CTLs) (black line, n = 72) and HLA-DR low in CTLs (red line, n = 68); this segregation was performed according to the threshold value given by the ROC curve with data from both cohorts.